Real-time enrollment status for this recurrent ganglioneuroblastoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 5:23 PM UTC
| NCT Number | NCT07437963 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Ganglioneuroblastoma |
| Phase | PHASE1 |
| Target Enrollment | 76 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 16, 2026 (17 hours ago) |
As of October 16, 2026: Clinical trial NCT07437963 is currently recruiting participants. This phase1 study for recurrent ganglioneuroblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07437963 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07437963 was last updated 17 hours ago (October 16, 2026). HelloStudys verifies this status automatically.